LONDON (Reuters) - Britain's healthcare watchdog NICE, which assesses the cost-effectiveness of medical treatments, has stopped short of... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/BfJVtOypPac/us-merck-britain-cancer-idINKBN167228
An experimental Merck & Co drug succeeded in preventing clinically serious cytomegalovirus (CMV) following bone marrow transplant and was... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/4yc3l15EpPo/us-merck-co-pharmaceuticals-antiviral-idINKBN1622C9
Merck & Co Inc, faced with patent expirations and increasing development costs for its high-profile Keytruda cancer immunotherapy, reassured... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/aTEQEDwArbo/us-merck-co-results-idINKBN15H19N
Trump met with the CEOs of Novartis AG, Merck & Co Inc, Johnson & Johnson, Celgene Corp, Eli Lilly & Co, Amgen Inc as well as the head of the... ...http://www.dnaindia.com/world/report-trump-meets-with-drugmakers-seeks-lower-prices-us-production-2303415
n">Merck & Co ( MRK.N ) on Friday posted seven years of information showing a high single-digit percentage annual average price hike across its... ...http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/MzgB9U1J8Jg/merck-co-drugpricing-idINKBN15B24P
Welcome Greetings! To our esteemed...